Area of research
Oncology · Infectious Diseases
Research interest
Research interests include Polyomavirus and related diseases, Parvovirus B19 Infection Studies, Cytomegalovirus and herpesvirus research, and HIV Research and Treatment.
Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia.
<i>OFF</i>
-Target Effects of Mycophenolic Acid on BK Polyomavirus Replication in Primary Human Renal Proximal Tubular Epithelial Cells
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia: A Swiss Transplant Cohort Study
Machine Learning-based Prediction of Active Tuberculosis in People With HIV Using Clinical Data.
Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10).
A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications.
Can you have a cake and eat it? Comparing reducing mycophenolate versus switching to everolimus for kidney transplants with new-onset BKPyV-DNAemia.
Rebound of Respiratory Virus Activity and Seasonality to Pre-Pandemic Patterns.
American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.
Xenotransplantation: from proof of concept to clinical reality.
Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.
Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication-an international CERTAIN registry study.
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research.
The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
Structural implications of BK polyomavirus sequence variations in the major viral capsid protein Vp1 and large T-antigen: a computational study.
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD).
Impact of bronchoalveolar lavage on the management of immunocompromised hosts.
How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort.
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy.
Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening.
Posoleucel for BK Polyomavirus in Kidney Transplant Recipients.
Single-cell RNA-sequencing of BK polyomavirus replication in primary human renal proximal tubular epithelial cells identifies specific transcriptome signatures and a novel mitochondrial stress pattern.
Longitudinal Analysis Over Decades Reveals the Development and Immune Implications of Type I Interferon Autoantibodies in an Aging Population
Impact of Swabbing Location, Self-Swabbing, and Food Intake on SARS-CoV-2 RNA Detection.
Transient biopsy-proven progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome (PML-IRIS) in an elderly woman without known immunodeficiency: a case report.
Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation.
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).